Portland Press Limited Board
Portland Press Limited Board acts as the Board of Directors of Portland Press to set and evaluate the overall strategic and operational strategies for the company, in collaboration with the related Editorial Boards.
Portland Press Ltd Board
Portland Press Limited Board
7 members
Professor Nigel Hooper
Professor Nigel Hooper
Nigel received his Ph.D. in biochemistry at the University of Leeds in 1987. He was then awarded a Mr and Mrs John Jaffé Donation Research Fellowship from the Royal Society to work on the proteolysis and membrane anchorage of mammalian cell surface peptidases. In 1989 he was appointed as lecturer in the Department of Biochemistry at Leeds, followed by promotions to senior lecturer, reader and in 2001 to Professor of Biochemistry. He served as Director of the Institute of Molecular and Cellular Biology (2007-2011), Pro-Dean for Research (2011) and Dean (2012-2014) of the Faculty of Biological Sciences at the University of Leeds.
In 2014 he was appointed to the Chair in Cell Biology in the Institute of Brain, Behaviour and Mental Health, Faculty of Medical and Human Sciences at the University of Manchester. He has held roles as Vice Dean for Research and Innovation in the Faculty of Biology, Medicine and Health (2016-2020) and Director of Dementia Research for the University (2015-2020). Since 2020 he has been Associate Vice-President for Research.
Professor Gurdyal Besra
Professor Gurdyal Besra
Professor Besra heads a world-leading multidisciplinary team investigating key aspects of the microbial physiology of the Mycobacterium tuberculosis cell wall and the potential role of iNKT/CD1d therapeutics. He has been awarded and successfully managed over 50 research grants valued at over £50 million from The Wellcome Trust, the Biotechnology and Biological Sciences Research Council (BBSRC) and the Medical Research Council (MRC).
He has published over 550 internationally peer-reviewed articles (e.g. in Science, Nature, Immunity, Journal of Experimental Medicine, and Proceedings of the National Academy of Science USA), reviews and book chapters, been cited 58,094 times and has an H-index score of 134 (Google Scholar).
Professor Sonia Rocha
Professor Sonia Rocha
Sonia Rocha is originally from the north of Portugal, where she obtained her undergraduate degree in Biology from Porto University, Portugal. After a year out doing a collaborative research project between Porto University and Uppsala University in Sweden, she started her PhD at the ETH-Zurich, Switzerland, working in mechanisms of ionizing radiation induced apoptosis. After completion, she then moved to the University of Dundee in Scotland to conduct postdoctoral research at the Department of Biochemistry, working on the crosstalk of tumour suppressors with NF-kappaB transcription factor family.
In November 2005, Sonia was appointed as Tenure Track Principal Investigator in the College of Life Sciences, University of Dundee, on a RCUK fellowship, starting her work on the field of hypoxia research. In 2010, was awarded Tenure and in 2011 she received a Cancer Research-UK Senior Research Fellowship. In 2012, she became deputy director of the Centre for Gene Regulation and Expression. In 2013, she was elected a Fellow of the Royal Society of Biology and in 2014 was promoted to Reader and 2016 to full Professor.
In 2017, she moved to the University of Liverpool, as Head of the department of Biochemistry. In May 2020, she became Executive Dean for the Institute of Systems, Molecular and Integrative Biology at the University of Liverpool, until December 2024. She was part of the UoA5 Biological Sciences REF2021 panel, and now REF2029 UoA5 panel. In 2024 she received the Biochemical Society Sir Philip Randle Lecture prize 2025. She is actively involved in teaching undergraduate and post-graduate students, as well in public engagement events. She serves on the scientific committees of several funding bodies (UKRI and Welcome, Finland, Poland, Ireland, Norway, Belgium) and also acts as an academic advisor or editor for several journals. From January 2026, she is the honorary treasurer for the Biochemical Society.
Chloe Frankish
Chloe Frankish
Chloe is a Chartered Accountant who has held Finance Director roles across several multinational organisations, including Finance Director for Europe at Croda and Finance Director, Latin America at Smith & Nephew. Prior to her career in the chemical and healthcare industries, she worked in Professional Services at PriceWaterhouseCoopers. Chloe has recently set up as an independent business owner in order to focus on her wellness practice.
Dr Kamran Naim
Dr Kamran Naim
Kamran is the Head of Open Science at the European Organization for Nuclear Research (CERN), where he leads a diverse portfolio of activities that aim to set the standards of a future open science ecosystem. Among these activities is managing the operations of the Sponsoring Consortium for Open Access Publishing in Particle Physics (SCOAP3), a global collaboration which has transitioned research output in the discipline of high energy physics to be almost entirely open access.
Kamran holds a PhD from Stanford University on Cooperative Models to support open access publishing and continues to work to support global efforts to address information inequity and global health challenges.
Dr Sarah Greaves
Dr Sarah Greaves
Sarah is an experienced publisher and editor. After leaving academia she worked as an Editor and Publisher at Nature for over 15 years, and was Chief Publishing Officer at Hindawi.
Sarah now runs her own publishing consultancy firm and focusses on launching products and services which are both editorially and commercially successful, including numerous Open Access journals.
Dr James Brown
Dr James Brown